Ticagrelor Versus Clopidogrel in Patients With STEMI Treated With Fibrinolysis

Volume: 73, Issue: 22, Pages: 2819 - 2828
Published: Jun 1, 2019
Abstract
The efficacy of ticagrelor in the long-term post–ST-segment elevation myocardial infarction (STEMI) treated with fibrinolytic therapy remains uncertain. The purpose of this study was to evaluate the efficacy of ticagrelor when compared with clopidogrel in STEMI patients treated with fibrinolytic therapy. This international, multicenter, randomized, open-label with blinded endpoint adjudication trial enrolled 3,799 patients (age <75 years) with...
Paper Details
Title
Ticagrelor Versus Clopidogrel in Patients With STEMI Treated With Fibrinolysis
Published Date
Jun 1, 2019
Volume
73
Issue
22
Pages
2819 - 2828
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.